Coding of specific subgroups of myelodysplastic syndromes in a population-based cancer registry: prospects for improvement
{{output}}
Myelodysplastic syndromes (MDS), reportable to US cancer registries for diagnoses since 2001, are a group of myeloid neoplasms heterogeneous in prognosis and treatment, and of growing importance in an aging population. In US registries that have reported incid... ...
